| Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade SC Wei, JH Levine, AP Cogdill, Y Zhao, NAAS Anang, MC Andrews, ... Cell 170 (6), 1120-1133. e17, 2017 | 1146 | 2017 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 412 | 2021 |
| Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies SC Wei, NAAS Anang, R Sharma, MC Andrews, A Reuben, JH Levine, ... Proceedings of the National Academy of Sciences 116 (45), 22699-22709, 2019 | 285 | 2019 |
| A genetic mouse model recapitulates immune checkpoint inhibitor–associated myocarditis and supports a mechanism-based therapeutic intervention SC Wei, WC Meijers, ML Axelrod, NAAS Anang, EM Screever, ... Cancer discovery 11 (3), 614-625, 2021 | 166 | 2021 |
| Negative co-stimulation constrains T cell differentiation by imposing boundaries on possible cell states SC Wei, R Sharma, NAAS Anang, JH Levine, Y Zhao, JJ Mancuso, ... Immunity 50 (4), 1084-1098. e10, 2019 | 85 | 2019 |
| Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC R Saddawi-Konefka, A O’Farrell, F Faraji, L Clubb, MM Allevato, ... Nature communications 13 (1), 4298, 2022 | 51 | 2022 |
| Understanding coral dispersal SW Davies | 6 | 2014 |
| Abstract A205: effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse S Mok, CR Duffy, NAAS Anang, JP Allison Cancer Immunology Research 7 (2_Supplement), A205-A205, 2019 | 1 | 2019 |
| Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1 S Mok, H Liu, NAAS Anang, JJ Mancuso, DA Çobanoğlu, JP Allison Cancer Research 84 (6_Supplement), 1354-1354, 2024 | | 2024 |
| Abstract A054: Anti-CTLA-4 generates memory T-cell with greater expansion and functionality than anti-PD-1 S Mok, H Liu, NAAS Anang, JJ Mancuso, DA Çobanoğlu, JP Allison Cancer Immunology Research 11 (12_Supplement), A054-A054, 2023 | | 2023 |
| Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1 S Mok, NAAS Anang, JJ Mancuso, JP Allison Cancer Research 83 (7_Supplement), 4149-4149, 2023 | | 2023 |
| Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC JS Gutkind, R Saddawi-Konefka, A O'Farrell, F Faraji, L Clubb, M Allevato, ... | | 2022 |
| 601 Sequencing immunotherapy before lymphatic ablation unleashes cDC1-dependent antitumor immunity in HNSCC R Saddawi-Konefka, A O’Farrell, F Faraji, M Allevato, Z Wang, V Wu, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse. S Mok, CR Duffy, NAA Anang, JP Allison CANCER RESEARCH 80 (19), 42-42, 2020 | | 2020 |
| Abstract A23: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse S Mok, CR Duffy, NAA Anang, JP Allison Cancer Research 80 (19_Supplement), A23-A23, 2020 | | 2020 |
| Negative costimulation constrains T cell differentiation SC Wei, R Sharma, NA Anang, J Levine, Y Zhao, J Wang, D Pe’er, ... The Journal of Immunology 200 (1_Supplement), 171.17-171.17, 2018 | | 2018 |
Jacob H. LevineColumbia UniversityVerified email at columbia.edu
